Print page content Print
Increase text size Decrease text size
Text Size
Power_of_the_Injectable_logo_with_syringe_and_shield

Medical Rationale for Service-Based Medicine

See how choosing an injectable medication, as a valuable service your practice provides, helps patients and pet owners.

PRESENTER:

John C. Angus, DVM, DACVD

Animal Dermatology Clinic
Pasadena, California

What matters most when treating patients?

Keeping a medical mindset focused on two critical factors — and making recommendations accordingly.

What matters most when treating patients? (Thumbnail)

What matters most when treating patients?

Service-based medicine provides value beyond the prescription (Thumbnail)

Service-based medicine provides value beyond the prescription

Noncompliance is only human (Thumbnail)

Noncompliance is only human

Q&A: What medical benefits do injectables provide that other therapies can't? (Thumbnail)

Q&A: What medical benefits do injectables provide that other therapies can't?

Q&A: Can using injectables help pet owners bond to my practice? (Thumbnail)

Q&A: Can using injectables help pet owners bond to my practice?

Key Points


Injectable medications offer many benefits:

  • You can turn to them to safely provide rapid, effective treatment.
  • Service-based medicine with injectables allows you to deliver an assured course of therapy that can improve pet health, is convenient for clients and brings added value to your practice.
  • In-clinic administration ensures 100 percent compliance, which can be important for treatment success.

Harness the medical benefits of injectables with effective medications from our portfolio:


More Reasons to Use Injectable Medications

Pricing Icon

Strategic Pricing »

Benefit your patients, clients and practice profitability

Recommendation Icon

Confident Recommendations »

Improve patient health, client loyalty and trust

Syringe Icon

Pricing Calculator »

Protect your pharmacy revenues

CYTOPOINT INDICATIONS: CYTOPOINT has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.

CONVENIA INDICATION: Dogs: CONVENIA is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Cats: CONVENIA is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

CONVENIA IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to CONVENIA. Do not use in dogs or cats with a history of allergic reactions to penicillins or cephalosporins. Side effects for both dogs and cats include vomiting, diarrhea, decreased appetite/anorexia and lethargy. See full Prescribing Information.

PROHEART 6 INDICATIONS: ProHeart 6 is indicated for use in dogs six months of age and older for the prevention of heartworm disease caused by Dirofilaria immitis. ProHeart 6 is indicated for the treatment of existing larval and adult hookworm (Ancylostoma caninum and Uncinaria stenocephala) infections.

PROHEART 12 INDICATIONS: ProHeart 12 is indicated for use in dogs 12 months of age and older for the prevention of heartworm disease caused by Dirofilaria immitis for 12 months. ProHeart 12 is indicated for the treatment of existing larval and adult hookworm (Ancylostoma caninum and Uncinaria stenocephala) infections.

PROHEART 6 AND PROHEART 12 IMPORTANT SAFETY INFORMATION: Use PROHEART 6 in dogs 6 months of age or older and PROHEART 12 in dogs 12 months of age or older. Do not administer to dogs that are sick, debilitated, underweight, have a history of weight loss, or to those previously found to be hypersensitive to the drug. Hypersensitivity reactions may occur in some dogs when PROHEART is administered alone or with vaccines. Anaphylactic and anaphylactoid reactions can result in death and should be treated immediately with the same measures used to treat hypersensitivity reactions to vaccines and other injectable products. Reported side effects in clinical trials included vomiting, lethargy, diarrhea, anorexia, and hypersensitivity reactions. People should avoid inhalation, contact with eyes, or accidental self-injection. Certification is required before veterinarians and staff administer these products.

For more information, please see full Prescribing Information for PROHEART 6 and PROHEART 12.

CONTACT US

1-888-963-8471

We are Mon–Fri, 8am–8pm ET

email to productsupport@zoetisus.comproductsupport@zoetisus.com

This site is intended for U.S. Animal Healthcare Professionals.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2019 Zoetis Services LLC. All rights reserved.